3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
4
Multiple Myeloma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Congenital Abnormalities
4
Sezary Syndrome
3
Myeloproliferative Disorders
3
Mycosis Fungoides
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Extranodal NK-T-Cell
3
Leukemia, Myeloid, Acute
3
Burkitt Lymphoma
3
Rectal Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Dendritic Cell Sarcoma, Interdigitating
2
Interventions
fludarabine phosphate
15
Whole-Body Irradiation
9
Peripheral Blood Stem Cell Transplantation
9
Mycophenolic Acid
9
Cyclophosphamide
8
Busulfan
8
Tacrolimus
7
Cyclosporine
5
ruxolitinib
4
fludarabine
4
Methotrexate
4
Antilymphocyte Serum
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
peginterferon alfa-2a
2
givinostat hydrochloride
2
givinostat
2
Stem Cell Transplantation
2
Radiotherapy
2
Melphalan
2
Etoposide
2
Carboplatin
2
veliparib
1
thymoglobulin
1
sonidegib
1
pomalidomide
1
merphos
1
bomedemstat
1
anagrelide
1
Transplantation
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thrombocythemia, Essential
×
In Situ Hybridization, Fluorescence
×
Clear all
No trials found.